NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gel Coat Biomaterials, Inc.

Gel Coat Biomaterials, Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.gelcoatbio.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$2.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gel Coat Biomaterials, Inc. is a biotechnology company that develops novel hydrogel technology for the stabilization of enzymes and other biomolecules.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biomaterial coatingsmedical device coatingshydrogel coatingsmedtech coatingsbiocompatibilitybio-coatingsurface modificationimplant coatingimplantable devicesmedical device surfacebiotech licensingzwitterionic polymersmedical device R&Dbio-interfacebiotech IP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gel Coat Biomaterials, Inc. Comps

Public and private peers based on sector, stage, and business model.

Gel Coat Biomaterials, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gel Coat Biomaterials, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2026
SeedFeb 22, 2024

Gel Coat Biomaterials, Inc. Investors

Notable investors and investment history

Gel Coat Biomaterials, Inc. investors
InvestorRounds
WASEDA University VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $1.26M round led by WASEDA University Ventures

  • Apr 20, 2026

    Monthly visitors increased 31% MoM.

Gel Coat Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gel Coat Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gel Coat Biomaterials, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2024
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.